<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02527005</url>
  </required_header>
  <id_info>
    <org_study_id>UIbadan</org_study_id>
    <nct_id>NCT02527005</nct_id>
  </id_info>
  <brief_title>A Comparative Study of Azithromycin and S-P as Prophylaxis in Pregnant HIV+ Patients</brief_title>
  <official_title>A Comparative Study of Azithromycin and Sulphadoxine-pyrimethamine as Prophylaxis Against Malaria in Pregnant HIV Positive Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Ibadan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Ibadan</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized controlled single blind prospective comparative study
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is intended to be a randomized controlled single blind prospective comparative
      study conducted to compare the efficacy of three monthly doses of sulphadoxine-pyrimethamine
      as intermittent preventive therapy for malaria with azithromycin in HIV positive pregnant
      women
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Actual">August 2016</completion_date>
  <primary_completion_date type="Actual">August 2016</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Level of malaria parasitemia at delivery in HIV positive women following administration of Azithromycin or Sulphadoxine- pyrimethamine as intermittent preventive therapy for malaria in pregnancy</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">140</enrollment>
  <condition>Malaria</condition>
  <condition>Pregnant</condition>
  <condition>HIV</condition>
  <arm_group>
    <arm_group_label>Azithromycin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Tabs Azithromycin 500mg daily for 3 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sulphadoxine-pyrimethamine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>500mg of sulphadoxine and 25mg of pyrimethamine 3 tablets every 4 weeks for 3 doses</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sulphadoxine-pyrimethamine</intervention_name>
    <description>Sulphadoxine-Pyrimethamine 500mg of Sulphadoxine and 25mg of Pyrimethamine 3tablets monthly for 3 doses</description>
    <arm_group_label>Azithromycin</arm_group_label>
    <arm_group_label>Sulphadoxine-pyrimethamine</arm_group_label>
    <other_name>Vitadar</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Azithromycin</intervention_name>
    <description>Tabs Azithromycin 500mg daily for 3 days</description>
    <arm_group_label>Azithromycin</arm_group_label>
    <arm_group_label>Sulphadoxine-pyrimethamine</arm_group_label>
    <other_name>Zithromax</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant HIV positive patients,

          -  Gestational age 16 weeks and above,

          -  No history of azithromycin or sulphadoxine-pyrimethamine use four weeks prior to
             recruitment

        Exclusion Criteria:

          -  Anaemia packed cell volume less than 30%,

          -  pre-existing medical conditions- diabetes mellitus,

          -  hypertension,

          -  allergy to sulphadoxine-pyrimethamine or azithromycin
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>AYODELE O AROWOJOLU, MBBS IBADAN</last_name>
    <role>Study Director</role>
    <affiliation>UNIVERSITY COLLEGE HOSPITAL,IBADAN,OYO STATE, NIGERIA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>ORIYOMI O AKINYOTU, MBBS IBADAN</last_name>
    <role>Principal Investigator</role>
    <affiliation>UNIVERSITY COLLEGE HOSPITAL, IBADAN, OYO STATE, NIGERIA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>ADENIKE F BELLO, MBBS IBADAN</last_name>
    <role>Study Director</role>
    <affiliation>UNIVERSITY COLLEGE HOSPITAL, IBADAN, OYO STATE, NIGERIA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>ADEOLA R ABDUS-SALAM, MBBS IBADAN</last_name>
    <role>Study Director</role>
    <affiliation>ADEOYO MATERNITY TEACHING HOSPITAL, IBADAN, OYO STATE</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University College Hospital,</name>
      <address>
        <city>Ibadan</city>
        <state>Oyo</state>
        <zip>200001</zip>
        <country>Nigeria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Nigeria</country>
  </location_countries>
  <reference>
    <citation>Taylor WR, Richie TL, Fryauff DJ, Picarima H, Ohrt C, Tang D, Braitman D, Murphy GS, Widjaja H, Tjitra E, Ganjar A, Jones TR, Basri H, Berman J. Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, Indonesia. Clin Infect Dis. 1999 Jan;28(1):74-81.</citation>
    <PMID>10028075</PMID>
  </reference>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 14, 2015</study_first_submitted>
  <study_first_submitted_qc>August 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 18, 2015</study_first_posted>
  <last_update_submitted>December 7, 2017</last_update_submitted>
  <last_update_submitted_qc>December 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Ibadan</investigator_affiliation>
    <investigator_full_name>ORIYOMI OMOTOYOSI AKINYOTU</investigator_full_name>
    <investigator_title>Senior Registrar</investigator_title>
  </responsible_party>
  <keyword>IPT</keyword>
  <keyword>malaria</keyword>
  <keyword>pregnant</keyword>
  <keyword>HIV positive</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Malaria</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pyrimethamine</mesh_term>
    <mesh_term>Sulfadoxine</mesh_term>
    <mesh_term>Fanasil, pyrimethamine drug combination</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

